Edward White
Stock Analyst at HC Wainwright & Co.
(1.85)
# 3,308
Out of 5,090 analysts
358
Total ratings
30.49%
Success rate
-8.47%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $10.59 | +211.61% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $8.73 | +94.73% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.77 | +214.47% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.80 | +57.89% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.34 | +1,094.03% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.52 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $10.00 | +700.00% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.00 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $3.68 | +443.48% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.15 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.68 | +335.37% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.46 | +287.00% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.11 | +623.98% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $18.01 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.56 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $31.46 | +74.83% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $19.75 | +158.29% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.25 | +33.46% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $5.89 | +850.76% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.97 | +182.72% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.24 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $27.42 | +2,452.88% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $35.95 | -16.55% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.11 | +985.97% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $10.59
Upside: +211.61%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $8.73
Upside: +94.73%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.77
Upside: +214.47%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.80
Upside: +57.89%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.34
Upside: +1,094.03%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.52
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $10.00
Upside: +700.00%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.00
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $3.68
Upside: +443.48%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.15
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.68
Upside: +335.37%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.46
Upside: +287.00%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.11
Upside: +623.98%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $18.01
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.56
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $31.46
Upside: +74.83%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $19.75
Upside: +158.29%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $5.25
Upside: +33.46%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $5.89
Upside: +850.76%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.97
Upside: +182.72%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.24
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $27.42
Upside: +2,452.88%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $35.95
Upside: -16.55%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.11
Upside: +985.97%